Invention Grant
- Patent Title: WNT signaling pathway inhibitors for treatments of disease
-
Application No.: US16900616Application Date: 2020-06-12
-
Publication No.: US11655233B2Publication Date: 2023-05-23
- Inventor: Fengtian Xue , Yan Shu
- Applicant: University of Maryland, Baltimore
- Applicant Address: US MD Baltimore
- Assignee: University of Maryland, Baltimore
- Current Assignee: University of Maryland, Baltimore
- Current Assignee Address: US MD Baltimore
- Agency: Morgan, Lewis & Bockius LLP
- Main IPC: C07D401/12
- IPC: C07D401/12 ; C07D413/14 ; C07D231/14 ; C07D207/416 ; C07D207/34 ; C07D249/06 ; C07D401/14 ; C07D403/12 ; C07D405/12 ; C07D413/12 ; C07D417/12 ; C07D417/14 ; A61K31/4439 ; A61K31/5377 ; A61K31/427 ; A61K31/4245 ; A61K31/4725 ; A61K31/353 ; A61K31/541 ; A61K31/422 ; A61K31/497 ; A61K31/4184 ; A61P1/16 ; A61P3/10 ; A61P35/00
Abstract:
Compounds and compositions are provided as inhibitors of the Wnt/β-catenin pathway for the treatment of diseases that implicate the same.
Public/Granted literature
- US20200299261A1 WNT SIGNALING PATHWAY INHIBITORS FOR TREATMENTS OF DISEASE Public/Granted day:2020-09-24
Information query
